Women make up more than half the global population. But for too long, medical research hasn't reflected that fact. Nuttall Women's Health is dedicated to funding research that will not only re-write that reality, but improve the vitality of women worldwide.

Investments

Iambic Therapeutics

NWH invested in Iambic for its AI-driven platform designed to maximize drug target selectivity and minimize off-target toxicity, widening the therapeutic window for cancer treatment broadly. NWH sees particular relevance in HER2-driven cancers affecting women.

Visit the Iambic website

Iambic Therapeutics

Share

Iambic Therapeutics

Share